Cannabis Industry Already Driving Industrial Lease Prices in Maine

The not-yet-legal cannabis industry is already driving up lease prices for industrial spaces that could be used for cultivation when the new laws take effect, according to a Portland Press Herald report. Lease prices in the Greater Portland area are already twice what they were six years ago, and local real estate brokers say that vacancy rates in the industrial sector are historically low.

“The economic opportunities for landlords are significant,” attorney Ted Kelleher of Drummond Woodsum said in the report. “Even though the process for the state granting licenses is a year away, people are already trying to secure properties.”

The medical cannabis industry has already helped to drive the low vacancy rates in the region, from 7.86 percent in 2011 to 3.38 percent in 2015. Maine cannabis growers are also more willing to pay higher rates for space – which have reached as much as $10 per square foot for the first time.

Greg Boulos of Portland’s CBRE | The Boulos Co. said the cannabis industry has “come out of the shadows,” explaining that cultivators are typically looking for properties that are 5,000 to 10,000 square feet and secluded from neighbors.

However, as the new law rolls out it’s likely that localities will choose to enact individual moratoriums and outright industry bans.

End


Indiana Veteran Pushing Lawmakers for MMJ Access

A U.S. Marines Veteran is emerging as a leading advocate for medical cannabis access in Indiana as lawmakers continue to drag their feet on the issue, according to an Indy Star report. Jeff Staker, who served in Operation Desert Storm and Operation Desert Shield, said he founded Hoosier Veterans for Medical Cannabis because “politicians listen to veterans.”

Staker, 51, was a driving force behind the Indiana American Legion’s decision to send a resolution to the state legislature calling on them to “remove restrictions from marijuana and reclassify it in a category that, at a minimum, will recognize cannabis as a drug with potential medical value.”

For the last six years a medical cannabis bill has been filed in the state legislature and for the last six years not a single one of them has even made it to a committee hearing.

The resolution by the Indiana American Legion mirrors the move by the national American Legions, calling on Congress to remove cannabis from the federal schedule.

Despite state not permitting medical cannabis use, Staker admits that he uses the drug “for medical purposes.” He has been on painkilling pharmaceuticals for at least the last 10 years and said he was interested in using cannabis after he noticed he was building a tolerance to painkillers.

“I’m the butt of jokes,” Staker said. “You know, ‘All I need is a doobie and a big bag of Doritos.’”

End


Massive Study Concludes Cannabis Has Legitimate Medicinal Value

In a sweeping study, The National Academies of Science, Engineering, and Medicine have concluded that cannabis does have legitimate medicinal value, but more research is required to determine the potential health risks, according to an Ars Technica report outlining the details.

In their 400-page analysis, researchers determined that cannabis and cannabinoids were effective in treating chronic pain and for chemotherapy-related vomiting and nausea in cancer patients, but observed that much more research is needed in order to determine the efficacy of its use as it relates to other conditions.

Additionally, the authors concluded that cannabis use is not linked to cancers attributed to smoking, but that smoking could increase respiratory problems and smoking cannabis while pregnant might lead to lower birth rates. It was not clear whether there were any long-term effects for children exposed to cannabis.

The researchers also debunked the ‘gateway’ myth associated with cannabis use, but indicated that many cannabis smokers use tobacco products and said that people who use cannabis are prone to becoming substance dependent. The committee determined that cannabis use may increase the risk of developing schizophrenia, anxiety and depression.

The committee is hopeful that the report could help steer policy discussion and concluded that cannabis should not be a Schedule I substance.

End


‘Cannabis Keurig’ Readying for April Launch

Massachusetts-based CannaKorp closed a $4.1 million Series A round of funding bringing it closer to launching its ‘cannabis Keurig’ – a single-use, pod-based vaporizer – in April, according to a BostInno report. The funding was led by cannabis investment firm Singularity Capital Management.

The company plans on first selling the CannacCloud through a network of dispensaries and processors in their home state, Rhode Island, Colorado, Washington, Oregon, and, eventually, Canada.

According to CEO and Co-Founder James Winkour, the system is expected to retail between $150 and $170. The pods are expected to run $6 to $10 depending on the strain. The products will be available at partnering dispensaries in legal U.S. states and would be available online for the Canadian market. The pods are made of recyclable aluminum in order to mitigate potential waste – a pressing sustainability concern of the traditional Keurig K-Cup.

Winker said people believe the device “helps normalize the industry” due to its design and that it would appeal to both current cannabis users who want a convenient and controlled way to consume, and those who are curious but uninterested in consuming it via traditional methods.

“We’re really focusing on ‘how do we educate the mainstream that cannabis has a beneficial effect?’” Winokur said in the report. “And that’s what we’re really after.”

End


MedMen Acquires NY MMJ Licensee Bloomfield Industries

MedMen, a California-based cannabis consulting and management firm, is acquiring New York licensed producer Bloomfield Industries, according to a Politico report. Bloomfield is one of just five companies allowed to cultivate, process, and dispense medical cannabis under the state’s limited medical cannabis program.

MedMen, who has a $100 million venture capital arm, is partnered with Wicklow Capital – the primary investor for another of the state’s five licensees, PharmaCann.

According to the report, Bloomfield had been experiencing “financial constraints” for at least six months; forced to miss vendor payments and entertain offers from investors. The company will continue to operate as “Bloomfield Industries” for the remainder of its initial two-year agreement.

Medical cannabis license transfers are not allowed under the Compassionate Care Act; however changes in ownership are permitted subject to Department of Health approval. Bloomfield is licensed to operate in New York City and grows its crop in Long Island City. They were selected to operate a dispensary in Manhattan but were never able to get it up and running.

Licensed companies in the state have long maintained that there is not enough demand due to the program’s regulatory restraints. In August, PharmaCann estimated it would be at least another 18 months before New York operators saw profitability. At that time, Etain Health and Vireo Health indicated they were in the red and Bloomfield did not return requests for comment.

Ari Hoffnung, CEO for Vireo said that Bloomfield “is a reminder” that New York’s operators “are dealing with a micro-market for medical marijuana.”

End


Guam Gov. Sends Adult-Use Bill to Legislature

Guam Gov. Eddie Calvo has sent a bill to the legislature that would legalize adult cannabis use in the U.S. territory, setting the age to consume the drug at 21, KUAM News reports.

In a letter to Speaker Benjamin J.F. Cruz, Calvo said the legislation is proposed “as a solution to the regulatory labyrinth” created by the voter-mandated medical marijuana program, adding that he does not “personally support recreational use of marijuana.”

“The program was well intended, seeking to provide for patients rather than leaving them in the dark or to the risks of the black market,” Calvo wrote. “While eliminating the black market is advantageous, the regulator nightmare that became the medicinal program would have replaced it with a gray market rife with corruption and cronyism.”

He explained that the new measure would not affect the current medical cannabis statutes and “the sin tax and age limit” applied under the recreational law would not apply to the medical market. The proposal includes a 15 percent tax that would be first used for the medical and recreational programs, including public health and education campaigns. The first $40 million raised annually would be directed to fund Guam Memorial Hospital operations.

The measure would allow adults 21 and older to grow up to six total cannabis plants providing that three or fewer are mature and it is not made for sale. Adults would be able to possess up to 1 ounce of flower and 8 grams of concentrates. Public consumption is now allowed and is punishable by a $100 fine. Those underage convicted of illegal possession would face a fine up to $500.

Sixty-eight percent of respondents in a KUAM News Twitter poll supported cannabis legalization on the island.

End


Nevada State Athletic Commission to Consider Reforming Cannabis Policies

The Nevada State Athletic Commission will consider removing cannabis from its banned substances list during a meeting on Friday, according to an MMA News report, citing an agenda for the meeting posted on the NSAC website.

The item is listed under the “New Business” section of the document, indicating there will be “discussion… to amend Nevada Administrative Code…to include… the possible exclusion of cannabinoids from the list of Prohibited Substances and Methods pursuant to passage of Nevada Ballot Initiative Question 2.”

The agenda called for public comment regarding all of the proposals to be discussed at the meeting.

According to the MMA News report, the NSAC’s suspension guidelines order an 18-month suspension for first-time violations for non-performance enhancing substances. In 2013, the body raised its allowable limit of THC from 50 nanograms-per-milliliter to 150 ng/ml.

Ultimate Fighting Championship competitor Nick Diaz had a 5 year suspension for testing positive for cannabis reduced to 18 months last January. It was the third time he had tested positive for cannabinoids, according to a Fox Sports report.

Cannabinoids would remain outlawed by the World Anti-Doping Agency, who provide the drug testing guidelines to the U.S. Anti-Doping Agency, who administer the drug tests for the UFC. However, mixed martial arts fighters in smaller promotions would likely be protected if the NSAC adopts the rule change.

End


Ariel University Offering Israel’s First MMJ Course

Israel’s Ariel University is offering the nation’s first academic course on medical cannabis, covering the plant’s medicinal history, active ingredients, clinical uses, legal status, and farming techniques, according to a Jewish Business News report. The course, designed for medical administration students, has enrolled 117 students.

Dr. Michael Dor, a senior lecturer at the university’s Faculty of Health Sciences, said that “dozens” of students were rejected do to the “very high” demand and “lack of space.”

Hebrew University of Jerusalem announced its Multidisciplinary Center on Cannabinoid Research at last year’s CannaTech conference. Hebrew University Professor Raphael Mechoulam is credited with first identifying THC.

Israel, the U.S., Canada, Italy, and Spain have a joint agreement to research cannabis. In Israel there are about 26,000 licensed medicinal cannabis patients in Israel and that figure is expected to double by next year.

Last month, an inter-ministerial committee of director generals comprised of the Ministries of Justice, Finance, Public Security, and Health proposed a plan to begin exporting medicinal cannabis. The committee said the industry would create thousands of agricultural jobs and be worth more than $2.6 billion annually.

Details of that proposal, which would need cabinet approval, are expected in the coming weeks.

End


Sessions Vague on Cannabis Questions During First Day of Confirmation Hearings

U.S. Attorney General nominee Republican Sen. Jeff Sessions was evasive when asked about how he would approach legalized cannabis during the first round of his confirmation hearings yesterday, testifying that handling those cases “won’t be an easy decision.”

When pressed by Democratic Sen. Patrick Leahy of Vermont about whether he would “investigate and prosecute sick people” using cannabis legally, Sessions said he “won’t commit to never enforcing federal law.”

“The Department of Justice under [Attorney General Loretta] Lynch and [former Attorney General David] Holder set forth some policies that they thought were appropriate to define what cases should be prosecuted in states that have legalized, at least in some fashion, parts of marijuana,” he said, indicating he would try to execute the duties of the office in a “fair and just way.”

During a follow-up question from Republican Sen. Mike Lee of Utah about state’s rights, Session’s said that if cannabis prohibition was “not desired any longer” at the federal level Congress “should pass a law and change the rule.”

“It’s not so much the Attorney General’s job to decide what laws to enforce,” Sessions said. “We should do our job and enforce laws effectively as we are able.”

Aaron Smith, executive director of the National Cannabis Industry Association, expressed hope that Sessions’ belief that the Justice Department’s current cannabis policy enforcement guidelines are “truly valuable…should lead [Sessions] to maintain the current federal policy.”

Marijuana Policy Project Director of Federal Policies also expressed optimism because Sessions was non-committal to enforcing federal cannabis laws.

“He was given the opportunity to take an extreme prohibitionist approach, and he passed on it,” Capecchi said in a Star-Telegram report.

However Erik Altieri, executive director of the National Organization for the Reform of Marijuana Laws, said that Sessions’ responses to the cannabis questions were unclear in terms of whether he would take any action.

“If anything, his comments are a cause for concern and can be interpreted as leaving the door open for enforcing federal law in legalized states,” he said.

Sessions’ confirmation hearings continue today.

End


Mettrum Acquires Network of Cannabis Clinics in Ontario, Canada

Licensed Canadian medical cannabis producer Mettrum Health Corp. has announced the acquisition of Bodystream – a network of 14 cannabis clinics across Ontario – the company announced in a press release.

Under the terms of the deal, Mettrum acquired all of the outstanding shares of Bodystream for $1 million in cash and issued 451,596 shares of Mettrum stock to current Bodystream shareholders. Mettrum will issue a maximum of 1,505,322 additional shares over the next five years based on Bodystream’s success.

“Mettrum’s physician-centric approach, and commitment to research resonates with our physicians and patients,” Brian Warner, president of Bodystream, said in the release. “We look forward to growing with Mettrum and working to develop a variety of services and products that will help improve the quality of life for patients.”

Michael Haines, CEO of Mettrum, indicated the companies have worked closely for the past two years and Bodystream “demonstrated an ability to scale rapidly while maintaining a high level of professional service.”

“With so many Canadians entering the [Access to Cannabis for Medical Purposes Regulations] system on a monthly basis and medical cannabis gaining traction as a viable therapeutic option for a variety of symptoms, the time to expand this aspect of our business is now,” he said.

Last month, it was announced that Canopy Growth Corp. would acquire Mettrum in a $320 million deal, which still has to be approved by both companies’ shareholders and a court.

End


Calaveras County, CA Measure Could Let Residents Vote to Ban Commercial Cultivation

Voters could have the opportunity to decide on banning commercial cannabis cultivation in Calaveras County, California after elections officials certified a petition to allow the issue to be determined in a special election, the Calaveras Enterprise reports.

However, the County Board of Supervisors could bypass citizens by adopting the measure immediately, or they could delay the process by asking for reports on the measure. Once those reports are completed, the board would have to either “adopt it” or schedule an election, County Clerk Recorder Rebecca Turner said, noting that the board “[doesn’t] have a lot of options.”

If the board decides to schedule a special election, it could happen as soon as May.

During the Board of Supervisors meeting, citizens from both sides of the fence voiced their concerns over the proposal.

Michael Falvey, a Mountain Ranch resident, said that he would rather see regulation than an outright ban, saying that a ban would just allow illegal growers to flourish.

“A ban is not regulation.” He said in the report. “I want regulation. I want the sheriff driving up the driveways. With a ban, you won’t have that.”

Members of the Calaveras Cannabis Alliance urged the board to send the issue to voters and thanked Sheriff Rick DiBasilio for his work eradicating illegal cultivators.

The proposal, while banning commercial operations, does permit personal-use growing up to three plants, which would only be allowed with a county permit. Under Proposition 64, which legalized adult-use cannabis in the state – citizens are allowed to grow up to six plants for personal use. Prop. 64 does not permit local government to outlaw personal cultivation.

If passed, the county would forfeit tax revenues from the legal cannabis market.

End


Vireo Health First NY Company Approved for MMJ Delivery

New York’s Vireo Health has received approval from the state Department of Health to launch a medical cannabis home delivery program – the first company approved for that purpose after the agency amended the medical cannabis program rules last month.

Vireo Health will offer deliveries in an eight-county zone, which includes Long Island, Westchester and all five New York City boroughs. In a press release, the company indicated that deliveries will be made in vehicles employing “cutting-edge safety features” including GPS tracking and a minimum of two employees will be present on all deliveries.

“Home delivery will not only help us to improve upon current services, but also expand our reach to those patients who are unable to travel,” Dr. Stephen Dahmer, Vireo’s chief medical officer, said. “Our team is excited to provide this service to all of our existing patients, and to have the opportunity to meet new patients in other parts of the state.”

Vireo CEO Ari Hoffnung said that the move will allow the company to “meet and exceed patient expectations.” The company expects to unveil details of the plan, such as pricing, “over the coming weeks,” and are planning to launch the service in 90 days.

End


CannaRoyalty to Acquire Stake in Canadian Cannabis Testing Lab

Canadian cannabis investment firm CannaRoyalty Corp. has signed a letter of intent to acquire a 20 percent equity interest in cannabis testing specialists Anandia Laboratories Inc. in a deal worth $4 million (USD $3,024,003.16) in cash, common shares, and equipment.

Anandia Labs holds a dealers license from Health Canada, permitting them analyze, extract, and cultivate cannabis for breeding and strain improvement. The dealers license allows the lab to expand its research efforts wider than licensed producers under the Access to Cannabis for Medical Purposes Regulations. Anandia serves as the testing facility for seven licensed producers in Canada.

Dr. Jonathan Page, Anandia co-founder, noted that the recent report by the Task Force on Cannabis Legalization and Regulation described analytical testing as “the ‘cornerstone’ for ensuring safe and effective products in the future cannabis market.”

“We have elected to partner with CannaRoyalty given their expertise in extraction, post-processing and the development of proprietary formulations,” Page said in a press release. “Building on our analytical chemistry expertise, our objective is to leverage our dealers license to build a national, best-in-class cannabis extraction and processing facility.”

Marc Lustig, CannaRoyalty CEO, said that the partnership with “exemplifies [their] approach of acquiring interests in high-value, strategic assets in the North American cannabis sector.”

“As the only independent Canadian testing facility specializing exclusively in cannabis, Anandia Labs is clearly well positioned given how crucial independent testing of cannabis products is to the future of the cannabis sector…” he said. “In addition, the value that we expect to help create through Anandia Labs’ dealers license for the extraction of derivatives – together with [their] impressive patent portfolio of genetics – gives CannaRoyalty shareholders exciting exposure to rapid and sustainable growth areas in Canada’s dynamic cannabis sector.”

The deal is expected to close on Jan. 31.

End


Florida Cannabis Licensing Case Heads Back to Administrative Judge Critical of Health Department Process

A cannabis licensing case is headed back to a Florida administrative law judge after the companies could not come to an agreement over who would control a disputed license, WUFT reports.

The companies, Plants of Ruskin and Tornello Landscape, found themselves in the running for a cannabis dispensing license in Southwest Florida after Judge John Van Laningham ruled that Alpha Foliage was incorrectly awarded the region’s license by the state Department of Health.

“Although the department was willing to issue one additional license in hopes of settling the matter, the parties were ultimately unable to come to an agreement,” attorneys for the Department of Health wrote in a request, asking to send the case back to the judge.

Doug Manson, a Plants of Ruskin representative, said the attempt by the Health Department was “like a shotgun wedding.”

“…We tried to put the two parties together, but we couldn’t make it work,” he said in the report. “We think the department should issue two licenses, because we think, under the law they can.”

Three of the five licensees authorized by the Health Department have been ruled as faulty by state administrative law judges, the report says. Van Laningham has said that the agency ignored their own evaluation rules during the licensing process.

End


Companies Partner with Cannabis Veterans Association to Pinpoint and Rename Therapeutic Strains

The Veterans for Cannabis Foundation has partnered with Medicinal Genomics and Courtagen Life Sciences to help develop brand and strain names that may be more palatable to potential government committees allowing cannabis data to, perhaps, get a fair review.

Under the co-promotion agreement, Medicinal Genomics will provide StrainSEEK, a strain identification and registration service, to the VFCF. The service will track CBD products created specifically for the foundation which will be available to VFCF members at a discount. The strains are designed to treat chronic pain, post-traumatic stress disorder, and neurological conditions.

“[The VFCF] mission of effecting change through data collection may ultimately help to reduce the unnecessary deaths amongst our veteran population, in particular for conditions where opioids are commonly prescribed.” Mike Catalano, head of marketing for Medicinal Genomics and Courtagen said in a press release. “Registering the genetic fingerprint of the cannabis strains used will help control the consistency of the products and the data collection efforts.”

By tracking the genetics, the original names of the strains will not be lost.

Joshua Littrell, founder of VFCF, said the StrainSEEK program helps the organization “take some of the guess work” out of cannabis treatments for veterans.

“VFCF will now be able to replicate and reproduce the experience for veterans in our program. Our veterans are begging for a treatment they can trust and that is uniform,” he said in the release. “Now they can rest assured knowing they are receiving the same treatment every time.”

End


Activist-Drafted Bill Would Legalize Washington Home-Growing

Activists in Washington have drafted a bill that would legalize home cannabis cultivation and sharing – provisions not included in I-502, the ballot initiative approved by voters in 2012.

“Washingtonians were told that the intent was to regulate cannabis like alcohol,” the authors of the ‘Washington state cannabis home growing act’ state. “Adults are allowed to brew beer and wine at home, therefore they should be allowed to grow their own cannabis at home.”

Under the measure, adults over 21 would be able to grow up to 18 cannabis plants and transport up to one pound of dried cannabis or six live plants. The proposal includes the ‘in-plain-view’ provision typical to personal-grow policies in other legal states, but provides that all transfers also be performed in private. Home extraction would be permitted, but must be in compliance with I-502.

The drafters say the amendment is needed because it was the voters’ intent “to stop the treatment of adult cannabis use as a crime.”

“The people do not give up their sovereignty to government in order to plant a seed, grow to harvest and enjoy [its] full produce as a right of nature, or to engage in culture and society with other consenting adults, or to develop one’s own personality,” the bill states. “Therefore, humanitarian compassion necessitates this act…”

The proposal has not been taken adopted or sponsored by any member of the Washington legislature.

End


Report: Cannabis Funding Up in Q4’16; Down 9% Overall

According to a CB Insights analysis, 2016 was a mixed bag for cannabis-related startups as funding and deal flow fell 9 percent, but the sector was bolstered by deals worth tens of millions of dollars.

The report found that cannabis funding deals totaled $225 million in 2016, down from the $220 million seen in the previous year. Deal flow – the quantity of investment opportunities in a sector – fell from 106 in 2015 to 96 last year, the report says. Deal flows peaked in the fourth quarter of 2016 at 32.

“On a quarterly basis, funding activity picked up in Q4’16, after deals fell for three consecutive quarters,” authors wrote in the report, published Jan. 6. “Funding in Q4’16 totaled $81M over 25 deals, more than tripling Q3’16′s funding total, but still falling short of the heights seen in Q1’15.”

Washington-based Privateer Holdings led the industry’s biggest 2016 deal with a $40 million convertible note round. The second largest pact belonged to Israel’s Syqe Medical, who struck a $20 million deal with Philip Morris International during a corporate minority round of fundraising. California-based MedMen rounded out the top three with their $15 million deal Cap-Meridian Ventures.

Privateer Holdings, who represented nearly half all quarter four cannabis funding, has raised $144 million since 2013 from investors, including Snoop Dogg’s cannabis-focused fund Casa Verde Capital and Founder’s Fund. Syqe Medical offers a metered-dose inhaler for precision dosing of medical cannabis.

Eight U.S. states enacted some form of adult-use or medical cannabis legalization last year.

End


Oregon’s Cannabis Testing Rules Causing Product Shortages

Oregon’s more stringent cannabis product testing rules have caused supply disruptions and, according to dispensary owners, have forced a 40 to 50 percent decrease in concentrate and edible sales, the Coast River Business Journal reports.

The new rules, which took effect on Oct. 1, have created a burden for state-certified testing laboratories, who cannot keep up with the demand. The issue is compounded by the fact that there are simply too few labs statewide to test cannabis products.

Omar Guerrero, co-owner of Clatsop County’s The Farmacy, called the last two months “a nightmare.”

“We didn’t have edibles or extract because of the new lab test requirements. It delayed everything. We suffered,” he said in the report. “We had all the products then we had nothing for a little more than a month.”

Oscar Nelson, co-owner of the Sweet Relief Dispensary in Astoria, estimates he has lost 33 percent of his edible and concentrates stock, causing “customer volatility.” He anticipates the market will stabilize, eventually, but not until “St. Patty’s Day 2018.”

“You’ve got less producers, fewer people bringing product to the market and that same product is going through a much more stringent funnel,” Nelson said. “It’s like we’ve got several bottlenecks back-to-back.”

Both Nelson and Guerrero are worried that the Oregon Health Authority is overwhelmed; Nelson said that the agency is beleaguered by producer applications making it tough to focus on the backlog.

End


South Dakota Cannabis Activists Gearing up for 2018 Ballot Initiatives

Pro-cannabis activists in South Dakota are planning to introduce both adult-use and medical cannabis proposals for initiated measures to go to a statewide vote in 2018, according to a KCCR-AM report. A notary error forced a medical cannabis measure off of South Dakota ballots last year.

Melissa Mentele, chairperson of New Approach South Dakota, indicated the adult-use measure would bring in “lots of revenue for the state and for educators,” explaining that the group is waiting on a summary from state Attorney General Marty Jackley before they can begin circulating the petition to citizens. Mantele said that the medical cannabis bill is “very similar” to their 2016 measure and that the group kept much of the language in that proposal the same because of the support it garnered last election cycle.

“We keep getting weak legislation or legislation that really doesn’t reflect who we are as South Dakotans,” Mentele said in the report. “We’ve been focusing on these bathroom bills for two years. I think people are ready to have fresh conversations for things that are really going to benefit our state.”

Mantele estimates that a recreational market in South Dakota would generate millions of dollars in tax revenues for the state.

End


Freshman Nebraska State Senator Plans to Introduce MMJ Bill in Upcoming Session

Nebraska is one of just five states without any sort of medical cannabis program but freshman nonpartisan State Sen. Anna Wishart is looking to change that this year, the Omaha World-Herald reports. Wishart said her measure would be of the limited variety – much like the proposal that fell just three votes short in the state last session – allowing for cannabis medicine in pill, liquid or vapor forms.

“There are people desperate and in need,” Wishart said in the report, noting that during her door-to-door campaigning a lot of people expressed support for a comprehensive medical cannabis program. “I can guarantee you they are in every single senator’s district.”

However, the Nebraska legislature saw 17 new Senators win seats in the last election, and while the body is officially a “non-partisan” majority, nearly all leadership posts in the Senate will go to conservative members. Advocates believe that even if the measure passes the legislature it will be vetoed by Republican Gov. Pete Ricketts.

“I’m putting more faith in a ballot initiative than a legislative bill,” Shelley Gillian, whose 14-year-old son suffers from daily seizures, said.

According to Matt Schweich, director of state campaigns for the Marijuana Policy Project, the organization is “very seriously” considering a ballot initiative push in 2018 if lawmakers fail to act.

“It’s going to be a public policy in Nebraska at some time in the future,” he said. “I hope that legislators see that.”

End


Should Chronic Cannabis Users be Worried about Cannabis Hyperemesis Syndrome?

The number of people living with cannabinoid hyperemesis syndrome is impossible to quantify as both doctors and patients are limited by the lack of research and the newness of the condition. The syndrome – commonly referred to as CHS – was first named by Australian researchers in a 2004 article in the medical journal Gut. In the article, authors described 19 patients who experienced severe abdominal pain and “cyclical pattern” vomiting that was only relieved by hot showers. The 19 patients had another thing in common – they all used cannabis.

Patient Perspectives

In interviews with Ganjapreneur, patients reflected on their experiences, describing unimaginable physical and mental anguish. Each story, although unique, was weighed with desperation, anger, and confusion. (*Some names have been changed to protect patient privacy).

J. Spence*, a 36-year-old from upstate New York, first used cannabis when he was a sophomore in high school, but didn’t start using “all day, every day” until his “late teens, early-20s.” It wasn’t until his mid-20s that he started having the attacks. He assumed it was acid reflux or “a bad gut,” attributing the illness to being “a little overweight,” his alcohol use, and unhealthy eating habits.

“At that point it wasn’t really bad enough to get hospitalized,” Spence said in a phone interview, explaining that doctors put him on medication to treat acid reflux. But as time went on, he only got sicker and the attacks became more frequent. “At one point I considered maybe it was long-term use of that making me sick.”

“What I thought was helping me…is actually what was making me sicker,” he said, describing “pouring sweat” which led him to the shower. “It became a learned behavior. Whenever I had an attack I got into the shower.”

Spence estimates that it was about 12 years ago when a doctor first considered that he had CHS but Spence admits he was bullish and it wasn’t until three or four years ago – and about 30 CAT scans over 10 years – that he was clinically diagnosed by an emergency room doctor. He was using cannabis “half recreationally, half medically” for anxiety and pain and was unable to change his lifestyle, so the attacks persisted. He finally quit “for good” last Thanksgiving.

Janine Durand*, a 47-year-old California resident, started using cannabis at 18-years-old, “hanging out with friends in [Los Angeles],” before it was legalized for medicinal use in the state in 1996.

“I wasn’t really a heavy smoker, just every once in a while,” Durand said in an interview. “It wasn’t until I was 27 when I really started smoking every day. And, at that time, I was just smoking Mexican weed – it’s not the highest grade stuff. Chronic, as they call it these days, wasn’t really a big thing yet.”

Durand had her first attack when she was about 29 – she was hospitalized for three days. Allen’s paper wouldn’t come for another five years and Durand was often in and out of emergency rooms and hospitals. It took 17 years for her to get correctly diagnosed.

“About a year-and-a-half ago I decided to start using concentrates and pretty soon I replaced marijuana completely with dabbing and I got really sick,” she explained. “And I was thinking ‘whatever is wrong with me it’s progressing’ and I dabbed more.”

She barely remembers the emergency room visit during which she was diagnosed and it wasn’t until she got home and looked it up on the Internet that she finally had an answer.

“It all made sense,” Durand said. “I read about the hot showers and it was the only this that alleviates these attacks to where you don’t just want to kill yourself – and I’m not exaggerating. It’s not unusual for me to be in a hot shower for four hours.”

Like Spence, Durand didn’t immediately quit. She was using it medically to manage pain and doctors had stopped prescribing her pharmaceutical pain killers due to her cannabis use. She stopped using concentrates and started using less, and weaker, cannabis – she kept getting sick. Durand quit for good on Oct. 3 and has neither had an attack nor taken a four-hour shower since.

“I’m very pro-marijuana,” she said. “I don’t believe that the majority of people will be affected at all.”

Stuart Margolis, a 47-year-old from Portland, Oregon, suffered from dozens of attacks, hospitalized “only” two or three times. He started smoking “heavily” at 18 and it wasn’t until his most recent attack last November that an emergency room doctor finally convinced him it was his cannabis use.

Margolis, and others interviewed for this piece, are members of a Facebook group dedicated to CHS support and awareness. He indicated that being a part of the online community helps him “[not] feel like…the only one experiencing this weirdness,” which he thinks of “in terms of an allergy.”

“I don’t think it was the [potency] of the weed itself,” he said in an interview. “For me, I think it was constant usage over long periods of time. I’m not sure I buy into the ‘buildup of toxic levels’ theory,” remarking that he never really used concentrates on a regular basis.

“Bodies change over time,” Margolis said. “I think my body doesn’t like whatever [cannabis is] doing to my system, whether it’s hormonal, or toxic metabolites, or really just an allergy.”

He explained that, for him, quitting cannabis was “super easy” compared to quitting narcotic pain killers – which he was prescribed “years ago” after getting hit by a horse. He hasn’t decided whether or not he is going to try to use cannabis again.

Physician Perspectives

Dr. Eric Lavonas, the chief of Emergency Medicine at Denver Health and spokesman for the American College of Emergency Physicians, has personally treated around 40 or 50 cases of CHS over the last four years. He explained that, while “it’s not an uncommon problem” in Colorado “obviously, most people who smoke marijuana don’t have any problem with vomiting.”

“But when you have a lot of people who smoke a lot of marijuana, even an uncommon problem like [CHS] affects a lot of people,” he said in a phone interview.

Lavonas worked in the emergency department prior to legalization in Colorado and said that while legalization has probably increased the number of people affected, more people are now willing to discuss their cannabis use which is going to lead to more diagnoses, and the overall increase in the cases will lead to less missed diagnoses. “Here in Colorado we’re pretty good at figuring this out…Every emergency physician has seen it.” The medical community is also beginning to make strides in treating the attacks without the showers, utilizing capsaicin oil.

The increased potency of cannabis products could also be at play, Lavonas said, observing that people smoking cannabis is “not a new thing” but ready access to high potency strains is what has changed.

“I am neither pro nor anti-marijuana. I am anti-vomiting,” he wrote in a follow-up email. “And I believe strongly that people should have accurate information when they make their choices.”

Dr. Bonni Goldstein, medical director for Canna-Centers, previously served as a pediatric emergency medicine physician for 15 years. Goldstein has seen two CHS patients, both in their 20s, and both patients only began experiencing attacks after using high potency cannabis products. After abstaining from using cannabis for at least one month, both patients were able to start using “very low dose” products.

“I’ve heard of people that cannot reintroduce but both of my patients were able to use cannabis again in small amounts, compared to what they were using,” she explained.

Goldstein, who now provides medical cannabis recommendations and treats very ill patients, indicated that she has never seen CHS – which she describes as an allergy – present in a strictly medical user and, in her experience, the condition “occurs only in people who are recreational users.”

However, Goldstein said there are countless numbers of “chronic, heavy” cannabis users that never develop CHS. “The big question mark is the individual’s body, metabolism, and absorption.”

“With this particular syndrome I do believe there are some people with a predisposition and then they are using high doses of THC-rich cannabis products,” she explained. “We really don’t know, but it’s theorized that there is a paradoxical effect at the receptor – it was working fine and then became sensitized.”

Goldstein also debunked some of the statistics employed in recent news reports. “In Arizona, they’re saying there was a 200 percent increase. If you look at the numbers there were three cases one year and six cases the next.”

“The reality is that just because there are people who have this does not mean that cannabis is a dangerous substance,” she said. “It is the easiest thing in the world – you abstain – and then if you want to tip-toe back into it, you tip-toe back into it and you don’t go high dose.”

End


Outgoing VT Gov. Pardons Nearly 200 People Convicted of Cannabis Crimes

In one of his final gubernatorial acts, outgoing Vermont Gov. Peter Shumlin pardoned 192 people formerly convicted of nonviolent cannabis offenses on Tuesday, clearing the records of individuals whose ages ranged from their 20s to 60s, the Christian Science Monitor reports. During his tenure, the Democrat has pardoned a total of 208 people, setting a new record in the state.

About 450 people applied for relief under the program and among those pardoned all but 15 live in Vermont. The pardon applied to convictions of nonviolent offenders who possessed less than one ounce and had no felonies, or convictions either of driving under the influence or reckless driving.

P.S. Ruckman Jr., a political science professor as Rock Valley College in Illinois, called Shumlin’s sweeping pardons “almost unimaginably safe” from criticism compared to 40 years ago.

“It’s highly significant,” Ruckman said in the report. “I think it’s likely we’ll see more of it.”

The governors of other states that have either legalized or decriminalized cannabis have not moved to clear the records of those convicted under old marijuana laws.

Governor Phil Scott, a Republican who took office in Vermont yesterday, has made no indication that he would continue the policies of his predecessor, although he told the Burlington Free Press that he believes the pardon offers make sense.

End


Australian Activist Raided Over Cannabis Oil Tried to Meet with Government Officials

The Australian woman raided by law enforcement for manufacturing medicinal cannabis oil, which she provided for free to terminally ill patients, said she has tried to meet with Health Department officials for more than two years prior to the crackdown at her home, according to an Australian Broadcasting Corporation report.

Jenny Hallam, 44, said she has worked with Greens MP Tammy Franks in the effort to legalize medicinal cannabis in South Australia but the bid “just can’t seem to get anywhere.”   

“I can’t even get a meeting with [SA Premier] Jack Snelling for the last two years … they keep putting it off to the drug and alcohol abuse minister, which we find insulting,” Hallam said in the report. “We’re not abusing anything; we’re not abusing any drugs. We’re using a drug responsibly and carefully and it’s saving people’s lives and it’s making people’s lives better and that’s all we’re trying to do.”

After the raid was made public, Franks called it “outrageous” saying patients had “been failed by the slowness of reforms.”

SA Innovation Minister Kyam Maher said that while the federal law does permit specialist doctors to prescribe medicinal cannabis, which is dispensed by pharmacies, further reforms will likely be discussed by South Australia officials during a meeting later this month. He said he would look into arranging a meeting between not only Hallam and state officials but “the industry in general.”

Snelling’s office indicated that the raid is in line with the law and is “a matter for police, the Director of Public Prosecutions and the courts.”

End


Alaska Collects First Cannabis Taxes

Alaska’s legal cannabis market earned $750,851.59 from Oct 29., the day the first store opened, to Dec. 9, according to an Alaska Dispatch News report. In November, seven cannabis cultivators paid $81,100 in taxes to the state Department of Revenue – mostly in cash.

Half of the tax revenues will be deposited into the state’s general fund, while the other half will be used for programs aimed at rehabilitating repeat criminal offenders.

Under the law, buds are taxes at $50 per wholesale ounce, while trim – stems and leaves – are taxed at $15 per wholesale ounce. In total, about 98 pounds of bud and 10 pounds of trim were sold in the state during the first full month of recreational sales, the Department of Revenue’s Tax Division Director Ken Alper indicated in the report. The numbers for November’s sales, due in December, are not yet available.

Despite recent supply shortages that have forced intermittent closing of some retail locations, last month three new stores opened in Anchorage and one in Fairbanks. Sitka’s first shop, Weed Dudes, opened on New Year’s Eve.

The first-month sales were generated by two shops in Fairbanks, one in Valdez, one in the Kenai Peninsula, and one in the state capital of Juneau.

End